Promethera Biosciences Announces First-Dosing in Phase 2a Clinical Study Evaluating World's First Liver Stem Cell Therapy in Late-Stage NASH Patients
MONT-SAINT-GUIBERT, Belgium & TOKYO--(BUSINESS WIRE)--May 9, 2019--Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, today announced the dos…
